Trial
NCT01663662
The Use of Tolvaptan to Prevent Renal Dysfunction in High Risk Patients With Heart Failure-Pilot Study
Phase IVWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
University of Michigan
Collaborators
Otsuka Pharmaceuticals
Condition
Heart Failure
Intervention
Tolvaptan
Why stopped
Lack of eligible patients
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2015-12-11